UNDER OFFER: Large-scale craft cultivator with GACP, IMC-GAP & EU-GMP certification
UNDER OFFER! Confidential sale mandate: Large-scale, GACP- & IMC-GAP-accredited, ultra premium craft cultivator in Ontario with 7,000 KG/yr production capacity, growing high margin exports, and EU-GMP certification
Listing ID:
14993305961
Licence(s) Held:
Standard Cultivation, Standard Processing, Research (Sensory)
Listing Details:
Fully-owned, large-scale craft cultivator with approx. 25,000 sq. ft of licensed cultivation space within 1.5 hours of GTA
Almost $40 million total spend on purpose built, fully automated, climate controlled facility with on site power generation, and advanced irrigation, HVAC/automation and cultivation systems
Capable of producing 7,000 KG/yr of ultra premium flower for supply into top retail brands and high margin export channels
A history of bringing unique and in-demand cultivars to market and producing ultra premium flower for a number of Canada's top cannabis brands
Strong focus on plant health with onsite tissue culture and pathogen indexing lab
Track record of positive EBITDA based on consistent high quality, high yield craft cannabis cultivation
International certifications and accreditations in hand including IMC-GAP (Israel) and GACP, with EU-GMP certification
Facility comes with significant physical assets and equipment
Sensory research licence enhances internal product testing capabilities
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.